Literature DB >> 23399042

Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?

Wynand P M M van de Ven1, Konstantin Beck, Florian Buchner, Erik Schokkaert, F T Erik Schut, Amir Shmueli, Juergen Wasem.   

Abstract

CONTEXT: From the mid-1990s several countries have introduced elements of regulated competition in healthcare. The aim of this paper is to identify the most important preconditions for achieving efficiency and affordability under regulated competition in healthcare, and to indicate to what extent these preconditions are fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland. These experiences can be worthwhile for other countries (considering) implementing regulated competition (e.g. Australia, Czech Republic, Ireland, Russia, Slovakia, US).
METHODS: We identify and discuss ten preconditions derived from the theoretical model of regulated competition and assess the extent to which each of these preconditions is fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland.
FINDINGS: After more than a decade of healthcare reforms in none of these countries all preconditions are completely fulfilled. The following preconditions are least fulfilled: consumer information and transparency, contestable markets, freedom to contract and integrate, and competition regulation. The extent to which the preconditions are fulfilled differs substantially across the five countries. Despite substantial progress in the last years in improving the risk equalization systems, insurers are still confronted with substantial incentives for risk selection, in particular in Israel and Switzerland. Imperfect risk adjustment implies that governments are faced with a complex tradeoff between efficiency, affordability and selection.
CONCLUSIONS: Implementing regulated competition in healthcare is complex, given the preconditions that have to be fulfilled. Moreover, since not all preconditions can be fulfilled simultaneously, tradeoffs have to be made with implications for the levels of efficiency and affordability that can be achieved. Therefore the optimal set of preconditions is not only an empirical question but ultimately also a matter of societal preferences.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2013        PMID: 23399042     DOI: 10.1016/j.healthpol.2013.01.002

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  22 in total

1.  The Relationship Between the Scope of Essential Health Benefits and Statutory Financing: An International Comparison Across Eight European Countries.

Authors:  Philip J van der Wees; Joost J G Wammes; Gert P Westert; Patrick P T Jeurissen
Journal:  Int J Health Policy Manag       Date:  2015-09-12

2.  Modest risk-sharing significantly reduces health plans' incentives for service distortion.

Authors:  Shuli Brammli-Greenberg; Jacob Glazer; Ruth Waitzberg
Journal:  Eur J Health Econ       Date:  2019-08-22

3.  Examining unpriced risk heterogeneity in the Dutch health insurance market.

Authors:  A A Withagen-Koster; R C van Kleef; F Eijkenaar
Journal:  Eur J Health Econ       Date:  2018-04-18

4.  Choice of insurer for basic health insurance restricted by supplementary insurance.

Authors:  Daniëlle M I D Duijmelinck; Wynand P M M van de Ven
Journal:  Eur J Health Econ       Date:  2013-07-26

Review 5.  Scientometric trends and knowledge maps of global health systems research.

Authors:  Qiang Yao; Kai Chen; Lan Yao; Peng-hui Lyu; Tian-an Yang; Fei Luo; Shan-quan Chen; Lu-yang He; Zhi-yong Liu
Journal:  Health Res Policy Syst       Date:  2014-06-05

6.  Switching health insurers: the role of price, quality and consumer information search.

Authors:  Lieke H H M Boonen; Trea Laske-Aldershof; Frederik T Schut
Journal:  Eur J Health Econ       Date:  2015-03-28

7.  Utilization of primary and secondary medical care among disadvantaged populations: a log-linear model analysis.

Authors:  Gregory Yom Din; Zinaida Zugman; Alla Khashper
Journal:  Glob J Health Sci       Date:  2014-04-27

8.  Improving access to essential health care services: the case of Israel.

Authors:  Wynand P M M van de Ven
Journal:  Isr J Health Policy Res       Date:  2016-03-04

9.  Improving risk equalization with constrained regression.

Authors:  Richard C van Kleef; Thomas G McGuire; René C J A van Vliet; Wynand P P M van de Ven
Journal:  Eur J Health Econ       Date:  2016-12-10

10.  How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.

Authors:  Wynand P M M van de Ven; René C J A van Vliet; Richard C van Kleef
Journal:  Eur J Health Econ       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.